<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2787">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03070613</url>
  </required_header>
  <id_info>
    <org_study_id>R37106</org_study_id>
    <nct_id>NCT03070613</nct_id>
  </id_info>
  <brief_title>Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery</brief_title>
  <official_title>Investigating the Use of Fluorescent Lectins to Identify Dysplasia and Cancer During Endoscopy and Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oxford</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a feasibility study investigating the use of a fluorescently conjugated lectin to
      identify colorectal dysplasia and cancer during colonoscopy and surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2017</start_date>
  <completion_date type="Anticipated">March 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Signal to background ratios of identified colonic lesions under white light and under fluorescence</measure>
    <time_frame>During procedure</time_frame>
    <description>This outcome measure compares the fluorescence signal of lesions identified during colonoscopy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of dysplastic and cancerous lesions identified under white light and under fluorescence</measure>
    <time_frame>During procedure</time_frame>
    <description>Number of lesions identified under white light colonoscopy will be compared to the number of lesions identified under fluorescence.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of dysplastic and cancerous lesions identified under white light and fluorescence in different subgroups</measure>
    <time_frame>12 months</time_frame>
    <description>Assessment of subgroups including ulcerative colitis, lesions suspicious of sessile serrated adenomas / traditional serrated adenomas</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resection margin of of lesions undergoing TEMS resection under white light and under fluorescence.</measure>
    <time_frame>12 months</time_frame>
    <description>Planned resection margins will be compared under white light and under fluorescence. R0/R1 resection rates will be assessed post operatively.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Colorectal Neoplasms</condition>
  <condition>Colorectal Polyp</condition>
  <arm_group>
    <arm_group_label>Fluorescent Lectin Application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fluorescein conjugated wisteria floribunda will be sprayed onto the colonic surface during colonoscopy or TEM surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluorescent Lectin Application</intervention_name>
    <description>Fluorescein conjugated wisteria floribunda (a lectin).</description>
    <arm_group_label>Fluorescent Lectin Application</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participant is willing and able to give informed consent for participation in the
             study.

          -  Male or female, aged 18 years or above

          -  Participants undergoing endoscopic procedures including colonoscopy and flexible
             sigmoidoscopy or transanal endoscopic microsurgery (TEMS), including robotic assisted
             TEMS

          -  In the investigator's opinion, is able and willing to comply with all study
             requirements

        Exclusion Criteria

          -  Participant who is unable to unwilling to give informed consent

          -  Female participant who is pregnant, lactating or planning pregnancy during the course
             of the trial. If there is an uncertainty regarding whether a woman could be pregnant,
             then they will be excluded from the study

          -  Participants with known egg allergies, ovalbumin allergy and soya allergies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Thomas G Barnes, MBChB</last_name>
    <email>lectins@nds.ox.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Thomas Barnes</name>
      <address>
        <city>Oxford</city>
        <state>Oxfordshire</state>
        <zip>OX3 7LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Thomas G Barnes, MBChB</last_name>
      <email>lectins@nds.ox.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Trevor Yeung, MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elizabeth Bird-Lieberman, MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Walter Bodmer, FRS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Boris Vojnovic</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lai Mun Wang, FRCPath</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James East, MRCP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simon Leedham</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Davide Volopi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gregory Weitsman</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susan Dutton</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Neil Mortensen</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 27, 2017</lastchanged_date>
  <firstreceived_date>February 22, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colonoscopy</keyword>
  <keyword>Fluorescence guided surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>To be confirmed</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
